Coronary artery disease (CAD) is the most Common type of heart disease, also referred to as coronary heart disorder. Coronary arteries are the essential blood vessels that supply your heart with blood, oxygen and nutrients. CAD occurs when these that provide blood to coronary heart muscle turn out to be hardened and narrowed. Atherosclerosis (regularly known as “hardening” or “clogging” of the arteries) is the buildup of cholesterol and fatty deposits (referred to as plaques) on the internal walls of the arteries. These plaques can avert blood go with the flow to the center muscle by clogging the artery or via causing abnormal artery tone and function.
According to recent (2010) estimates, due to aging and population growth, the annual CVD events in China is projected to increase by >50% between 2010 to 2030, even if risk factors stay at year 2000 levels; This would result in 39 million CAD events and 130 million strokes (total 169 million).
Treatment for CAD involves lifestyle changes, if necessary, drugs and certain medical procedures. Various drugs that are used to treat CAD are Cholesterol-modifying medications, Beta blockers, Nitroglycerin, Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). Some of the Procedures to restore and improve blood flow like Angioplasty and stent placement (percutaneous coronary revascularization), Coronary artery bypass surgery.
Some of the Major researches on Coronary artery disease in China are Relation of resisting to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status, Flotillin-2 Gene Is Associated with Coronary Artery Disease in Chinese Han Population.